T. Rowe Price Associates »

Disc Medicine shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Disc Medicine (IRON) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Disc Medicine

Tip: Access up to 7 years of quarterly data

All positions including Disc Medicine held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Disc Medicine by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $34M 591k 57.76
2023-09-30 $25M 528k 46.98
2023-06-30 $9.0M 203k 44.40

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Nvidia Corporation Comm Stk (NVDA)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Intuit Comm Stk (INTU)
Servicenow Comm Stk (NOW)
Fiserv Comm Stk (FI)

View all positions for T. Rowe Price Associates

Top funds holding Disc Medicine

Atlas Venture Life Science Advisors
Paradigm Biocapital Advisors
OrbiMed Advisors
Perceptive Advisors
Frazier Life Sciences Management
Vanguard Group
T. Rowe Price Associates
Deerfield Management Company
Henderson Group
Alliancebernstein
Caption Management
5AM Venture Management
Franklin Resources
Citadel Advisors
Ikarian Capital

View all funds holding Disc Medicine